Cited by 852Diabetes Treatment and ManagementDiabetes Management and ResearchDiabetes Management and Education

The DOI matches its Crossref record; 112 of the 114 references it cites were found in a registry or an index.

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

Open access

ElSayed, Nuha A., Aleppo, Grazia, Aroda, Vanita R., Bannuru, Raveendhara R., Brown, Florence M., Bruemmer, Dennis, Collins, Billy S., Hilliard, Marisa E., Isaacs, Diana, Johnson, Eric L., Kahan, Scott, Khunti, Kamlesh, Leon, Jose, Lyons, Sarah K., Perry, Mary Lou, Prahalad, Priya, Pratley, Richard E., Seley, Jane Jeffrie, Stanton, Robert C., Gabbay, Robert A.·2023·Diabetes Care

DOI 10.2337/dc23-s009PMC PMC9810476

Open this paper in CoChat — free account Open PDF

Abstract

The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/dc23-s009

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD)
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Self-citation
Untitled work
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Buse, J. B., Wexler, D. J., Tsapas, A., Rossing, P., Mingrone, G., Mathieu, C., D’Alessio, D. A., & Davies, M. J. (2020) · Diabetes Care · doi:10.2337/dci19-0066 · Cited by 1,192
Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Chiang, J. L., Kirkman, M. S., Laffel, L. M., Peters, A. L., & Authors, O. B. O. T. T. 1. D. S. (2014) · Diabetes Care · doi:10.2337/dc14-1140 · Cited by 1,039
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
Gerstein, H. C., Sattar, N., Rosenstock, J., Ramasundarahettige, C., Pratley, R., Lopes, R. D., Lam, C. S. P., Khurmi, N. S., Heenan, L., Del Prato, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108269 · Cited by 829
Self-citation

Show all 114 references

Research works printed but not linked: 1

Peters, 2013, American Diabetes Association/JDRF Type 1 Diabetes Sourcebook

Sorted by citations

Items 701–800 of 852

Saudi Consensus on the Usage of Sodium-Glucose Cotransporter-2 Inhibitors on the Management of Chronic Kidney Diseases
Alsheikh, A., Al-Jedai, A. H., Almudaiheem, H., Alaidarous, S. B., Alshehri, A. A., Elbadawi, H., Alghamdi, S., Aljehani, F., Alobaidi, S. A., Altuwaijri, T. A., et al. (2023) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2023.1412045
Real-world Data of Glycemic Control in a Suburban Population in Northern India during the COVID-19 Pandemic
Revale, J., & Revale, P. J. (2023) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_23_23
Particularités des complications microangiopathiques du diabète chez le sujet âgé
Buysschaert, M., Boureau, A., Dhane, Y., & Bauduceau, B. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(23)00297-3
PERIOPERATIVE PREPARATION OF PATIENTS RECEIVING GLP-1 RECEPTOR AGONISTS
Daniyalova, N. D. (2023) · Современные проблемы науки и образования · doi:10.17513/spno.33167
Characterizing Prescribing Patterns of Diabetes Medications at an Adult Medicine Clinic: A Focus on Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors
Shtoyko, A. N., Murphy, M. B., Harris, J. L., Toomey, C., & Phillips, E. M. (2024) · Diabetes Spectrum · doi:10.2337/ds22-0095
In-Home Management of Diabetes and Obesity
Kowalski, S. L., & Gifford, S. (2024) · Home Healthcare Now · doi:10.1097/nhh.0000000000001223
The Many Faces and Facets of Dysglycemia
HEILE, M. K. (2024) · Clinical Diabetes · doi:10.2337/cd23-0093
Evolution of insulin therapy in the light of innovative technologies of the 21st century
Demidova, T. Y., & Titova, V. V. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-439
Antidiabéticos Não Insulínicos na Abordagem da Hiperglicemia nos Doentes Hospitalizados por Doença Aguda Não Crítica
Lopes, S., Maia, A., Melo, P., Abreu, S., Paiva, I., & Barros, L. (2024) · Acta Médica Portuguesa · doi:10.20344/amp.20858
Comparative analysis of hospitalization risk for incident heart failure in non‐Hispanic Black versus non‐Hispanic White individuals with type 2 diabetes on empagliflozin (Empa‐AA): Insights from real‐world data
Mishriky, B. M., Cummings, D. M., Fu, Y., Halladay, J. R., Jones, S., Boan, A. D., Jones, S. B., Patil, S. P., Powell, J. R., Adams, A. D., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15499
Dental Extractions Associated With Reduced Insulin Requirements in an Individual Using Concentrated Insulin: A Case Study
Stewart, M. P., Powers, R., & Litten, K. P. (2024) · Clinical Diabetes · doi:10.2337/cd23-0101
Dual GIP and GLP-1 agonists and changes in the lipid spectrum
Karásek, D. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.006
Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study
Hoog, M. M., Maldonado, J. M., Dixon, R. W., Halpern, R., Buysman, E. K., Gremel, G. W., Huang, A., & Кониг, М. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01542-5
Non-insulin Medications for the Management of Type 2 Diabetes
Hayes, M. J. (2024) · Home Healthcare Now · doi:10.1097/nhh.0000000000001232
c. Part III: Treatment with Antidiabetes Drugs—Effects on Blood Pressure and Central Hemodynamics
Nilsson, P. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00011-8
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study
Terui, S., Igari, M., Tsuno, T., Okuyama, T., Inoue, R., Kyohara, M., Terauchi, Y., & Shirakawa, J. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01557-y
HIV ile Yaşayan Bireylerin Takibinde Bütüncül Yaklaşım: Primer Kardiyovasküler Koruma
Başaran, N. Ç., & Ünal, S. (2024) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20249950
Inflammatory risk of albumin combined with C-reactive protein predicts long-term cardiovascular risk in patients with diabetes
Xu, X., Zhu, H., Wang, H., Zhu, X., Liu, L., Zhang, F., Zhou, H., Zhu, M., Dai, L., & Cai, L. (2024) · Aging · doi:10.18632/aging.205709
Weight, Glucose and Insulin
Hindmarsh, P. C., & Geertsma, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824548-4.00035-8
An update of contemporary insulin therapy
Tsai, Y., Gu, Y., & Jiang, Y. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14212 · Cited by 1
Prevalence of Vitamin B12 deficiency in patients with type 2 diabetes mellitus on Metformin therapy at a single centre in Johannesburg, South Africa
Kondlo, B., Cassimjee, Z., Olivier, C., & Bayat, Z. (2024) · Wits Journal of Clinical Medicine · doi:10.18772/26180197.2024.v6n1a2 · Cited by 1
Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal‐bolus insulin regimens in treat‐to‐target trials: A narrative review
Russell-Jones, D. L., Bailey, T. S., Lane, W. S., Mathieu, C., & Pedersen‐Bjergaard, U. (2024) · Diabetic Medicine · doi:10.1111/dme.15339 · Cited by 1
Insulin therapy for elderly patients with type 2 diabetes mellitus
Petunina, N. A., Кузина, И. А., Эдуардовна, Т. М., Валерьевна, Г. Е., Степановна, М. Н., Олеговна, Щ. А., & Викторович, Х. М. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-127
A INFLUÊNCIA DE ASPECTOS DA RELIGIOSIDADE EM UM ACOLHIMENTO INSTITUCIONAL NA CIDADE DE BELÉM-PA: VIOLÊNCIA E DESAFIOS
Melo, A. F. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-229-4_001
PERCEPÇÕES DE GERENTES, PROFISSIONAIS E USUÁRIOS SOBRE AS PRÁTICAS INTEGRATIVAS E COMPLEMENTARES OFERTADAS NA ATENÇÃO PRIMÁRIA À SAÚDE
da Silva, P. H. B., de Barros, L. C. N., Gomes, C. B. O., Dallegrave, D., de Barros, N. F., & de Oliveira, E. S. F. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-229-4_008
AVANÇOS E DESAFIOS NA CONSOLIDAÇÃO DA ATENÇÃO PRIMÁRIA COMO PRIMEIRO ACESSO: UMA REVISÃO INTEGRATIVA DA LITERATURA
Simarelli, M. M. G., da Rocha, A. M. P., Neto, A. D. H. G., Lima, S. D. D. H. G., Guilherme, F. D., Gonçalves, A. M. S., & Luccia, T. P. D. B. D. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-229-4_004
CUIDADO: REFLEXÕES SOBRE A ATENÇÃO PRIMÁRIA À SAÚDE
Cristino, L. S., & Pinheiro, P. A. D. S. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-229-4_005
ATUAÇÃO NA ATENÇÃO PRIMÁRIA À SAÚDE DURANTE A PANDEMIA DA COVID-19: RELATO DE EXPERIÊNCIA
Ferreira, D. D. S., de Matos, T. N. F., Pereira, R. B., do Amaral, J. F., Martins, C. B., & Jorge, M. S. B. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-229-4_003
MANEJO CLÍNICO DA DIABETES MELLITUS TIPO 2: UMA REVISÃO NARRATIVA DA LITERATURA
Bandeira, L. B., Vital, P. F., Tritany, É. F., & Filho, B. A. B. D. S. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-229-4_007
EXPLORANDO O TRANSTORNO DISSOCIATIVO DE IDENTIDADE (TDI): REVISÃO SISTEMÁTICA
Lima, M. V. G., Pimentel, N. V. D. S., Cavalcante, A. F. P., Paiva, F. P., Pereira, R. B., Guedes, F. V. A., da Silva, L. M., dos Santos, D. F., Pereira, C. A., & do Amaral, J. F. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-229-4_006
A INSERÇÃO DA PSICOLOGIA COMO CIÊNCIA E PROFISSÃO NA ATENÇÃO BÁSICA EM SAÚDE: PERSPECTIVAS E DESAFIOS
Bezerra, C. O., & Lima, A. D. C. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-229-4_002
PSICOLOGIA SOCIAL NA REDE CUCA: SAÚDE MENTAL E A POLÍTICA DE JUVENTUDE
Dias, H. N. C., & Bittencourt, P. D. C. M. (2024) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-229-4_009
Disease latency bias and the protective effect of metformin against age-related macular degeneration
Beare, N. A. V. (2024) · Eye · doi:10.1038/s41433-024-03112-2
Factors Influencing Insulin Adherence among Outpatients with Type 2 Diabetes Mellitus and the Impact of Pharmaceutical Intervention: A Randomized Clinical Trial
He, T., Wang, H., Sun, W., Li, L.-T., Li, L., & Ji, C. (2024) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/2024/5518977 · Cited by 1
AN ANALYSIS OF ANTIMICROBIAL AND ANTIDIABETIC FIXED DOSE COMBINATIONS BANNED IN INDIA
Hotwani, J. H., & Rao, A. (2024) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2024.v17i6.50741
Digital Health and Pharmacoadherence
Aungst, T. D., & Mukherjee, S. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13244-5.00011-0
Dapagliflozin-Saxagliptin Combination - The Quest for Optimal Glycemic Control With Cardio-Renal Protection in Type 2 Diabetes Mellitus: An Expert Consensus in Indian Settings
Ghosh, S. K., WANGNOO, S. K., Chittawar, S., Damodharan, S., Kadam, Y., Kalra, P., Kumar, K. P. S., Periyandavar, I., Sharma, S. K., & Zargar, A. H. (2024) · Journal of Endocrinology and Metabolism · doi:10.14740/jem946
An alpha-test of Diabetology.co.in—an algorithm-driven personalized and precision medicine prescription system for treatment-naive patients with type 2 diabetes
Lakhani, O., Gupta, A., Tripathi, P., & Mehta, C. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01368-8
Gz Enhanced Signal Transduction assaY (G Z ESTY) for GPCR deorphanizationPreprint
Franchini, L., Porter, J. J., Lueck, J. D., & Orlandi, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.26.605282
Chronische Niereninsuffizienz bei Typ-2-Diabetes – die stille Bedrohung einer Multisystemerkrankung
Günes-Altan, M., & Schmieder, R. E. (2024) · Aktuelle Kardiologie · doi:10.1055/a-2318-3452
Improvement in Glycemic Indices and Point in Range by Addition or Switch to IDegAsp–Real-World Evidence
Seshadri, K., Polisetti, S., & Tippisetty, S. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_35_24
SGLT2 Inhibitor, an Agent for Diabetes, Heart, Kidney… and Stroke
Yang, T., Lee, J., & Oh, J. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2024.0214
GLP-1 receptor agonists in clinical practice
Pérez, A. (2024) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2024.02.015
A very rare cause of markedly elevated CA 19–9: Glucagon-like peptide-1 receptor agonists
Liang, R., Fu, Z., Chen, L., Zhou, S., & Jiao, H. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101578
A single - center, retrospective observational study comparing the efficacy of empagliflozin and dapagliflozin as add-on therapy in type 2 diabetic patients
Hau, N. V. V., Bang, N. V., Xuan, N. T., Linh, P. N. T., Thoi, N. T. N., Trang, V. T., Trung, P. M., Chi, L. V., & Thuy, N. H. (2024) · Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế · doi:10.38103/jcmhch.16.8.12
Los niveles plasmáticos elevados de TNF-R1 predicen el desarrollo de eventos isquémicos agudos en pacientes coronarios con diabetes
Mas, S., Tarín, N., Cristóbal, C., Soto‐Catalán, M., Pello, A. M., Aceña, Á., Lumpuy‐Castillo, J., Garcés, C., Gómez‐Guerrero, C., Landaluce, C. G., et al. (2024) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2024.08.004
Diabetes Management with Current Guidelines.
Karadeniz, Y. (2023) · doi:10.69860/nobel.9786053359111.12
Evaluation of hemoglobin A1c control among Medicare advantage patients not meeting non‐insulin diabetes medication adherence metric
Doles, M., Caswell, B., & Conty, N. (2024) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.2033
Is Bangladesh’s people aware of “diabetes mellitus: the disease of prosperity” health care management?
Mukta, U. S. (2024) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2024.11.00281
Sofortige Tripelkombinationstherapie als neue Therapiestrategie bei unbehandeltem Typ-2-Diabetes
Schamarek, I. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01246-1
Primary Prevention of Stroke: Identifying High-Risk Patients
Kaslow, J., & Kernan, W. N. (2024) · Springer eBooks · doi:10.1007/978-3-031-66289-8_36
Reinforcement Learning Adjustment of Conventional Insulin Therapy for People with Type 1 Diabetes
Serafini, M. C., Fushimi, E., & Garelli, F. (2024) · IEEE Biennial Congress of Argentina (ARGENCON) · doi:10.1109/argencon62399.2024.10735891
Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services
Kweyete, O. M. T., Woods, D., Okoumba, J., Guo, J. S., & Allen, J. M. (2024) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.2050
The influence of information platform based personalized self-management prescription on type 2 diabetes in China: A real-world cohort study (Preprint)Preprint
Amuti, R., Amuti, R., Kadier, A., Jiang, M., & Maihemuti, A. (2024) · doi:10.2196/preprints.69267
Impacto del inicio de la monitorización flash de glucosa en pacientes adultos con diabetes tipo 1
Sahagún, R. J. (2024) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/72390
Efficacy and safety of switching to insulin glargine 300 U/mL in people with type 2 diabetes uncontrolled on basal insulin in China: A post hoc subpopulation analysis of the INITIATION study
Chen, L., Wan, H., Han, J., Yang, C., Shao, H., Li, J., Yan, W., Xiao, J., Sun, Y., Li, M., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16144
Concomitant use of sodium-glucose co-transporter 2 inhibitors and metformin and the risk of osteomyelitis reporting: a disproportionality analysis based on FAERS database
Wu, J., Wang, X., Zhao, X., & Zhu, S. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2446431
Impact of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Events in Type 2 Diabetes
Shabbir, H., Rasikh, M., Bashir, K., Khan, H. A., Khan, H. S., Raza, M., & Shahid, S. H. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i1.496
ADVANTAGES AND DISADVANTAGES OF USING METFORMIN IN AGING RELATED DISEASES
Tola, S. M., Faradz, S. M., Utomo, A. R. H., & Mustofa, S. (2025) · Jurnal Kedokteran dan Kesehatan Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya · doi:10.32539/jkk.v12i1.461
Population profile and glycemic control following initiation or switch of injectable therapies in Tianjin, China: A real‐world retrospective cohort study of adults with type 2 diabetes
Zhang, Q., Fan, Y., Liu, X., Zhang, M., Zhang, J., Du, Q., Kang, L., & Chen, L. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.14415
Combining Glucagon-Like Peptide-1 Receptor agonists and Sodium-Glucose Cotransporter-2 Inhibitors in the management of Type 2 Diabetes Mellitus: A protocol for a scoping review
Builes-Montaño, C. E., Suarez-Rodriguez, A. F., & Carreño, J. (2025) · F1000Research · doi:10.12688/f1000research.159628.1
Risk Stratification for Post-Hospitalization Case Management in Diabetes: Integrating Clinical and Socioeconomic Data (Preprint)Preprint
Lee, S.-Y., Saleem, M., Land, A. M., Delaney, E. W., Garretson, A., Patel, M., Hall, A. G., Westrick, S. C., Ovalle, F., Cherrington, A., et al. (2025) · doi:10.2196/preprints.72624
Preoperative glycemic control and postoperative clinical outcomes in patients with type 2 diabetes mellitus undergoing bariatric surgery
Brambilla, B., Blume, C. A., de Carvalho, T. R., Alessi, J., & Schaan, B. D. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.02.016
Timing of Insulin Glargine 300 U/ML: Does It Really Matter in Terms of Efficacy and Safety at Insulin Initiation?
Sanyal, D., & Mitra, A. (2025) · Cureus · doi:10.7759/cureus.80050
Promoting provider adherence to American Diabetes Association guidelines with a diabetes care bundle
Noor, B., Benton, K., & Vazquez, C. (2025) · The Nurse Practitioner · doi:10.1097/01.npr.0000000000000300
Elevated plasma levels of TNF-R1 predict the development of acute ischemic events in coronary patients with diabetes
Mas, S., Tarín, N., Cristóbal, C., Soto‐Catalán, M., Pello, A. M., Aceña, Á., Lumpuy‐Castillo, J., Garcés, C., Gómez‐Guerrero, C., Landaluce, C. G., et al. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.100735
Healthcare Resource Utilization and Costs in Individuals Who Discontinue Liraglutide and Who Switch from Liraglutide to Once-Weekly Injectable Semaglutide
Tan, X., Brady, B. L., Xie, L., & Paprocki, Y. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01741-8
Low- and Very-Low-Calorie Diets and Medication Use in Hospitalized Patients with Obesity: A Cross-Sectional Study
Braga, S. D. Q., Oliveira, M. C. A. M., Chamorro, M. J., de Jesus, N. A., Oliveira, R. A. M., da Silva, D. A. R., Rios, D. L. S., & das Mercês, M. C. (2025) · Healthcare · doi:10.3390/healthcare13111336
Practical Applications of Wearable Devices for Diagnosis and Monitoring
Kim, H. (2024) · MechEcology · doi:10.23104/me.2024.10.3.2.23
Association between weekend catch-up sleep and glycemic control among individuals with diabetes: a population-based study
Wang, P., Li, Q., Yu, X., Wu, L., Liu, J., Zheng, Y., Liu, Z., Yao, J., Fan, S., & Li, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1461367 · Cited by 1
МЕДИКАМЕНТОЗНАЯ КОРРЕКЦИЯ ФАКТОРОВ ПРОГРЕССИРОВАНИЯ НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНИ ПЕЧЕНИ У ПАЦИЕНТОВ С САХАРНЫМ ДИАБЕТОМ 2-ГО ТИПА И ОЖИРЕНИЕМ
Поздняк, А. О., Елсукова, О. С., & Никитина, Е. А. (2025) · University therapeutic journal · doi:10.56871/utj.2025.49.81.011
THE IMPACT OF COVID-19 PANDEMIC ON THE CONSUMPTION OF ANTIDIABETIC DRUGS IN SERBIA: A JOINPOINT TREND ANALYSIS
Filimonovic, J. S. (2025) · Praxis medica · doi:10.70949/pramed202504000f
Mind the Gap: Exploring Discrepancies in Perception and Practice among Diabetes Mellitus Patients and their Caregivers
Hari, V., & Thajuddeen, K. (2025) · Journal of the Association of Physicians of India · doi:10.59556/japi.73.0999
Evaluating time to treatment intensification among drug naïve type 2 diabetes patients: a comparison of initial combination therapy vs step-therapy approaches
Majd, Z., Cheruvu, S. S., Chen, H., Johnson, M. L., Birtcher, K. K., Serna, O., & Abughosh, S. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2682989
Decreased insulin dose-adjusted hemoglobin A1c in adults with cystic fibrosis-related diabetes treated with elexacaftor-tezacaftor-ivacaftor
Burnet, E., Grunewald, D., Larger, É., Camus-Bablon, F., Eisenhauer, C., Mifsud, F., Martin, C., Honoré, I., Kanaan, R., Carlier, N., et al. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100407
A Gamified Cardiometabolic Health Curriculum Utilizing a Student Response System for Internal Medicine Residents
Hsieh, J.-C. J., Bagha, Z. M., Weintraub, S. F., Jnani, J., & Block, L. (2025) · Cureus · doi:10.7759/cureus.87718
Comparison of safety profile of DPP4 inhibitors with SGLT2 inhibitors in type 2 diabetes mellitus: systematic review
Nimavat, Z. R., Patel, A. N., Gor, A. P., & Ganguly, B. (2025) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20252377
Potential Therapeutic Benefits of Pepper Fruit Extract on Hyperglycemia and Dyslipidemia in Obese Type 2 Diabetic Mice
Sadeghi, M., Afshari, M., Oh, J. P., Ryu, T. H., Choi, H. R., Jang, H. N., Kim, G. J., & Lee, S. (2025) · Cureus · doi:10.7759/cureus.89199
Transforming the Primary Care Journey with Generative AI: A Foundation Model to Boost Efficiency, Quality, and Engagement
Yang, B., Lee, J., Tsai, T. K., Sattler, A. L., Shah, S., Smith, M. A., & Lin, S. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09716-y
Effectiveness and Safety of Insulin Glargine 300 U/ml in High-Risk Subgroups (Renal Impairment and Older Age ≥ 70 years) of Insulin-Naïve People with Type 2 Diabetes: A Post hoc Analysis of Real-World ATOS Study
Tirosh, A., Khan, N., Vargas‐Uricoechea, H., Galstyan, G. R., Shaikh, A. S., Makkar, B. M., Mabunay, M. A., Melas‐Melt, L., Pilorget, V., & Karalliedde, J. J. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01785-w
Heterogeneity in Economic Value of SGLT2is for Type 2 Diabetes: Subgroup Modeling Cost-Effectiveness Analyses
Chong, K. S., Yang, C., Wang, C., Ou, H., & Kuo, S. (2025) · PharmacoEconomics · doi:10.1007/s40273-025-01536-6
Effectiveness and use of evidence-based cardiovascular preventive therapies in type 2 diabetes patients with established or high risk of atherosclerotic cardiovascular disease
Tian, J.-Q., Lin, Y., Zhang, Z.-J., Peng, Y.-T., Ye, J., & Wang, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1637035
Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS ‐ AP ‐combo and SURPASS ‐3
Lee, B., Lee, C. B., Lim, S. K., Kim, S. G., Kim, N. H., Won, J. C., Lee, W. J., Kang, M. J., Yuh, J. Y., Du, L. Y., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70111
Indian Clinicians’ Perspectives on Utilizing Dapagliflozin-Based Combination Therapy for the Management of Obesity in Patients With Type 2 Diabetes Mellitus
Agrawal, M. B., Ahluwalia, A. I., Boddula, R., Baidya, A., Saikia, H., Mathew, A., Naryanan, P., Arjun, R., Reddy, M., Kesarkar, R. N., et al. (2025) · Cureus · doi:10.7759/cureus.92594
Relationship between anti-diabetic medication use and glycaemic control: a retrospective diabetes registry-based cohort study in Singapore
Chan, S. L., Yap, C. J. Q., Xu, Y.-Q., Chia, S. Y., Salim, N. N. M., Lim, D. M., Choke, E. T. C., Carmody, D., Tan, G. C. S., Goh, S., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-098650
Time to first optimal glycaemic control and associated factors among adult patients with diabetes at the University of Gondar Comprehensive Specialized Hospital, northwest Ethiopia: a retrospective cohort study
Getahun, A. D., Ayele, E. M., Tsega, T. D., Anberbr, S. S., Geremew, G. W., Biyazin, A. A., Taye, B. M., & Mekonnen, G. A. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-096615
Real-world Analysis of Clinical Characteristics and Treatment Patterns in Patients with Type 2 Diabetes in the United Arab Emirates
Alawadi, F., Jabbar, A., Fiad, T. M., Hafidh, K., Hassanein, M., Tangı, F., Rai, S., Tebbs, K. W., Harrison, L., & Isailovic, T. V. (2025) · Dubai Diabetes and Endocrinology Journal · doi:10.18502/ddej.v31i1.19920
Risk Factors for Claudication and Management to Modify Them
Devadoss, R., & Alonso, A. (2025) · Springer eBooks · doi:10.1007/978-3-032-02460-2_7
CREATION OF THE PREGNANCY MICE MODEL TO STUDY THE EFFECT OF GLP-1/GIP AGONISTS
Akylzhanova, G., Bakenova, O., Abetov, D. A., Umarov, A., Musaeva, Z., Akilzhanova, G. A., Sarbassov, D. D., & Akilzhanova, A. R. (2025) · Ġylym men densaulyķ saķtau. · doi:10.34689/sh.2025.27.4.008
Adherence in initiators of combination therapy among drug-naïve patients with type 2 diabetes: A real-world study using group-based trajectory model
Fatima, B., Cheruvu, S. S., Ofili, S. C., Majd, Z., & Abughosh, S. (2025) · JAPhA Pharmacotherapy · doi:10.1016/j.japhar.2025.100024
Biguanides
Odegard, P. S., Winter, A., & Capoccia, K. L. (2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch06
New Concepts in Cardiac Rehabilitation and Secondary Prevention After Acute Coronary Syndrome
Zwisler, A., & Taylor, R. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11869-2.00029-1
Additional file 2 of Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetes
Newson, R. S., Spaepen, E., Liao, B., Bower, J. K., Bhattacharya, I., Artime, E., & Polonsky, W. (2024) · Figshare · doi:10.6084/m9.figshare.25670322
Additional file 2 of Effects of finerenone and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus: a systematic review and meta-analysis
Gu, X., Jiang, S., Yang, Y., & Li, W. (2024) · Figshare · doi:10.6084/m9.figshare.24987936
Additional file 3 of Trends and regional differences in antidiabetic medication use: a nationwide retrospective observational study
Csatordai, M., Benkő, R., Matúz, M., Engi, Z., Csupor, D., Lengyel, C., & Doró, P. (2024) · Figshare · doi:10.6084/m9.figshare.26711594
Additional file 1 of Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Wang, P., Zhang, Y., Xu, W., He, J., Peng, L., Feng, Y., Xu, P., Chong, W., Hai, Y., Jia, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24940445
Additional file 2 of Hypoglycemia in patients with type 2 diabetes mellitus during hospitalization: associated factors and prognostic value
González-Vidal, T., Rivas‐Otero, D., Gutiérrez-Hurtado, A., Felgueroso, C. A., Tamés, G. M., Lambert, C., Delgado, E., & Torre, E. L. M. (2024) · Figshare · doi:10.6084/m9.figshare.24719386
Additional file 3 of Hypoglycemia in patients with type 2 diabetes mellitus during hospitalization: associated factors and prognostic value
González-Vidal, T., Rivas‐Otero, D., Gutiérrez-Hurtado, A., Felgueroso, C. A., Tamés, G. M., Lambert, C., Delgado, E., & Torre, E. L. M. (2024) · Figshare · doi:10.6084/m9.figshare.26648898
Additional file 1 of Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis
Huynh, D. J., Renelus, B. D., & Jamorabo, D. S. (2023) · Figshare · doi:10.6084/m9.figshare.24873072
Additional file 1 of Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetes
Newson, R. S., Spaepen, E., Liao, B., Bower, J. K., Bhattacharya, I., Artime, E., & Polonsky, W. (2024) · Figshare · doi:10.6084/m9.figshare.25670216

Authors: ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., Kahan, S., Khunti, K., Leon, J., Lyons, S. K., Perry, M. L., Prahalad, P., Pratley, R. E., Seley, J. J., Stanton, R. C., & Gabbay, R. A.
ORCID: ElSayed, Nuha A.
Aleppo, Grazia
Aroda, Vanita R.
Bannuru, Raveendhara R.
Brown, Florence M.
Bruemmer, Dennis
Collins, Billy S.
Hilliard, Marisa E.
Isaacs, Diana
Johnson, Eric L.
Kahan, Scott
Khunti, Kamlesh
Lyons, Sarah K.
Perry, Mary Lou
Prahalad, Priya
Pratley, Richard E.
Seley, Jane Jeffrie
Stanton, Robert C.
Gabbay, Robert A.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2022-12-12
Volume: 46
Issue: Supplement_1
Pages: S140-S157
ISSN: 0149-5992 (ISSN-L)
DOI: 10.2337/dc23-s009
PMC: PMC9810476
OpenAlex: W4311264067
Semantic Scholar: f75bf88f7fa4c4c0cf940dad739ba96bb6d15d64
Cited by: 851
References: 114
Citations by year: 2026: 64 · 2025: 149 · 2024: 360 · 2023: 277 · 2022: 1
FWCI: 28.05
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.diabetesjournals.org/journals/pages/license (vor)
Locations: Diabetes Care (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords: glycemic control, pharmacotherapy, diabetes mellitus, antidiabetic drugs, clinical guidelines, treatment goals, quality of care
MeSH terms: Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks